Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition
Samuel James Brake(University of Tasmania), Sukhwinder Singh Sohal(University of Tasmania)
Cited by 22
Related Papers
A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial–mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study
|International Journal of COPD|2014|80
Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition
|ERJ Open Research|2022|43
Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis
|ERJ Open Research|2023|28
Epithelial–mesenchymal transition changes in nonsmall cell lung cancer patients with early COPD
|ERJ Open Research|2023|20